(Q45394082)

14 December 2017

title

Gamma-glutamyltransferase activity in chronic dialysis patients and renal transplant recipients with hepatitis C virus infection (English)

1 reference

14 December 2017

1 reference

J F Souza

1

1 reference

14 December 2017

C A Longui

series ordinal

2

1 reference

14 December 2017

L A Miorin

series ordinal

3

1 reference

14 December 2017

Y A Sens

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Transplantation Proceedings

14 December 2017

published in

1 reference

14 December 2017

volume

40

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

1319-1323

1 reference

Unexpected distribution of hepatitis C virus genotypes in patients on hemodialysis and kidney transplant recipients.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Chronic liver disease in kidney recipients with hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

DNA sequencing with chain-terminating inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Hepatitis C virus infection in renal transplant patients: a comparative study with immunocompetent patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Is serum gamma glutamyltransferase a marker of oxidative stress?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Cryoglobulinemia in kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.03.157

10.1016/J.TRANSPROCEED.2008.03.157

7 January 2021

Identifiers

DOI

1 reference

14 December 2017

1 reference